Ruxolitinib Clears Steroid-Refractory Sweet Syndrome in PV Case
A Swiss case report shows ruxolitinib cleared steroid-refractory histiocytoid Sweet syndrome in six weeks in a PV patient already in hematologic complete remission.
Topic
Paraneoplastic
Topic